Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis

Inflammatory Bowel Diseases

Volumn 15, Issue 6, 2009, Pages 810-811

  Criscuoli, Valeria ^a   Mocciaro, Filippo ^a   Orlando, Ambrogio ^a   Rizzuto, Maria Rosa ^b   Renda, Maria Concetta ^b   Cottone, Maria ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; BACTERIUM DETECTION; CASE REPORT; CLINICAL FEATURE; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; GENE FUNCTION; HEMATOCHEZIA; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LEUKAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM BIOPSY; RELAPSE; STEROID THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS INFECTIONS; HUMANS; LEUKAPHERESIS; VIRUS REPLICATION;

EID: 67650252520     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20742     Document Type: Letter

References (9)

1. Loftus EV Jr, Alexander GL, Carpenter HA. Cytomegalovirus as an exacerbating factor in ulcerative colitis. J Clin Gastroenterol. 1994; 19:306-309.
2. Pfau P, Kochman ML, Furth EE, et al. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol. 2001;96:895-989.
3. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:2137-2142.
4. Sissons JGP, Bain M, Wills MR, et al. Latency and reactivation of human Cytomegalovirus. J Infect. 2002;44:73-77.
5. Vancikova Z, Dvorak P. Cytomegalovirus infection in immunocompetent and immuno-compromised individuals: a review: Curr Drug Targets Immune Endocr Metabol Disord. 2001;1:179-187.
6. Helbling D, Breitbach TH, Krause M. Disseminate cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol. 2002;14:1393-1395.
7. Fietze E, Prosch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients: the role of tumor necrosis factor. Transplantation. 1994;58:675-680.
8. Döcke WD, Fietze E, Syrbe U, et, al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet. 1994;343-268-269.
9. Dumont LJ, Luka J, VandenBroeke T, et al. The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods. Blood. 2001;97:3640-3647.